These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38640895)

  • 41. N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.
    Zhang H; Lu R; Huang J; Li L; Cao Y; Huang C; Chen R; Wang Y; Huang J; Zhao X; Yu J
    Cell Mol Life Sci; 2024 Feb; 81(1):73. PubMed ID: 38308713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NAT10 mediated mRNA acetylation modification patterns associated with colon cancer progression and microsatellite status.
    Zhang H; Shan W; Yang Z; Zhang Y; Wang M; Gao L; Zeng L; Zhao Q; Liu J
    Epigenetics; 2023 Dec; 18(1):2188667. PubMed ID: 36908042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N4-acetylcytidine (ac4C) promotes mRNA localization to stress granules.
    Kudrin P; Singh A; Meierhofer D; Kuśnierczyk A; Ørom UAV
    EMBO Rep; 2024 Apr; 25(4):1814-1834. PubMed ID: 38413733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. iRNA-ac4C: A novel computational method for effectively detecting N4-acetylcytidine sites in human mRNA.
    Su W; Xie XQ; Liu XW; Gao D; Ma CY; Zulfiqar H; Yang H; Lin H; Yu XL; Li YW
    Int J Biol Macromol; 2023 Feb; 227():1174-1181. PubMed ID: 36470433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA.
    Li Z; Li D; Yang T; Yao C
    Cancer Biol Ther; 2023 Dec; 24(1):2274143. PubMed ID: 37948132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation.
    Shrimp JH; Jing Y; Gamage ST; Nelson KM; Han J; Bryson KM; Montgomery DC; Thomas JM; Nance KD; Sharma S; Fox SD; Andressen T; Sinclair WR; Wu H; Allali-Hassani A; Senisterra G; Vedadi M; Lafontaine D; Dahlin JL; Marmorstein R; Walters MA; Meier JL
    ACS Med Chem Lett; 2021 Jun; 12(6):887-892. PubMed ID: 34141066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NAT10 accelerates pulmonary fibrosis through N4-acetylated TGFB1-initiated epithelial-to-mesenchymal transition upon ambient fine particulate matter exposure.
    Shenshen Wu ; Yin L; Han K; Jiang B; Meng Q; Aschner M; Li X; Chen R
    Environ Pollut; 2023 Apr; 322():121149. PubMed ID: 36731737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NAT10-mediated N4-acetylcytidine modification is required for meiosis entry and progression in male germ cells.
    Chen L; Wang WJ; Liu Q; Wu YK; Wu YW; Jiang Y; Liao XQ; Huang F; Li Y; Shen L; Yu C; Zhang SY; Yan LY; Qiao J; Sha QQ; Fan HY
    Nucleic Acids Res; 2022 Oct; 50(19):10896-10913. PubMed ID: 35801907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Site-Specific Synthesis of
    Bartee D; Nance KD; Meier JL
    J Am Chem Soc; 2022 Mar; 144(8):3487-3496. PubMed ID: 35172571
    [No Abstract]   [Full Text] [Related]  

  • 50. NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity.
    Yang Z; Wilkinson E; Cui YH; Li H; He YY
    Toxicol Appl Pharmacol; 2023 Oct; 477():116688. PubMed ID: 37716414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma.
    Pan Z; Bao Y; Hu M; Zhu Y; Tan C; Fan L; Yu H; Wang A; Cui J; Sun G
    Cell Death Discov; 2023 Feb; 9(1):56. PubMed ID: 36765042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LSA-ac4C: A hybrid neural network incorporating double-layer LSTM and self-attention mechanism for the prediction of N4-acetylcytidine sites in human mRNA.
    Lai FL; Gao F
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126837. PubMed ID: 37709212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma.
    Zhang W; Gao J; Fan L; Wang J; He B; Wang Y; Zhang X; Mao H
    Heliyon; 2023 Jun; 9(6):e17103. PubMed ID: 37484432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review.
    Jin G; Xu M; Zou M; Duan S
    Mol Ther Nucleic Acids; 2020 Jun; 20():13-24. PubMed ID: 32171170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases.
    Zhang Y; Lei Y; Dong Y; Chen S; Sun S; Zhou F; Zhao Z; Chen B; Wei L; Chen J; Meng Z
    Pharmacol Ther; 2024 Jan; 253():108576. PubMed ID: 38065232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK/ERK signaling pathway.
    Liu Y; Wang X; Liu Y; Yang J; Mao W; Feng C; Wu X; Chen X; Chen L; Dong P
    Cell Death Dis; 2023 Nov; 14(11):712. PubMed ID: 37914704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of NAT10 as ac4C writer in diseases.
    Xie L; Zhong X; Cao W; Liu J; Zu X; Chen L
    Mol Ther Nucleic Acids; 2023 Jun; 32():359-368. PubMed ID: 37128278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
    Chen X; Hao Y; Liu Y; Zhong S; You Y; Ao K; Chong T; Luo X; Yin M; Ye M; He H; Lu A; Chen J; Li X; Zhang J; Guo X
    Adv Sci (Weinh); 2023 Nov; 10(32):e2302705. PubMed ID: 37818745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DeepAc4C: a convolutional neural network model with hybrid features composed of physicochemical patterns and distributed representation information for identification of N4-acetylcytidine in mRNA.
    Wang C; Ju Y; Zou Q; Lin C
    Bioinformatics; 2021 Dec; 38(1):52-57. PubMed ID: 34427581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression.
    Xu N; Zhuo J; Chen Y; Su R; Chen H; Zhang Z; Lian Z; Lu D; Wei X; Zheng S; Xu X; Wang S; Wei Q
    Br J Cancer; 2024 Feb; 130(2):201-212. PubMed ID: 38040817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.